Home The Action Management Committee Harry van Goor (NL)

Thu,27Apr2017

Prof. Harry van Goor

Full Professor
Department of Pathology and Medical Biology,
University Medical Center Groningen 

T: +31-50-3619529/ +31-641194350
F: +31-50-3619107
E: This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Interests

  • Therapeutic applications of hydrogen sulfide
  • Gastransmitters in renal disease and preeclampsia
  • Hydrogen sulphide in ischemic conditions
  • Hydrogen sulfide in aging
  • Hydrogen sulphide in neurodegeneration

Selected Recent Publications

  • Bos EM, Wang R, Snijder PM, Boersema M, Damman J, Fu M, Moser J, Hillebrands JL, Ploeg RJ, Yang G, Leuvenink HG, van Goor H : Cystathionine -lyase protects against renal ischemia/reperfusion by modulating oxidative stress.  J Am Soc Nephrol. 24:759-70, 2013
  • Bos EM, Leuvenink HG, Snijder PM, Kloosterhuis NJ, Hillebrands JL, Leemans JC, Florquin S, van Goor H : Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury.  J Am Soc Nephrol. 20:1901-5, 2009
  • Snijder PM, de Boer RA, Bos EM, van den Born JC, Ruifrok WP, Vreeswijk-Baudoin I, van Dijk MC, Hillebrands JL, Leuvenink HG, van Goor H : Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolism.   PLoS One 10;8 :e63291, 2013
  • Snijder PM, van den Berg E, Bakker SJL, Leuvenink HGD,  van Goor H: Emerging Role of Gasotransmitters in Renal Transplantation . American Journal of Transplantation, in press
  • Holwerda Km, Bos EM, Rajakumar A, Ris-Stalpers C, van Pampus MG, Timmer A, Erwich JJHM, Faas MM, van Goor H, Lely AT: Hydrogen sulfide producing enzymes in pregnancy and preeclampsia. Placenta 33:518-521, 2012 

ESF

COST

POLICY STATEMENT: Biomedicine and Molecular Biosciences Action BM1005 is funded by COST, through its implementing agent the European Science Foundation.